Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families.

(00:33)
 Dr. Hasadsri, can you tell the audience a little bit about yourself and your background?

(01:32)
 And Ms. Cabral?

(02:03)
 Can you please give the audience a brief overview of this assay?

(03:33)
 Which patients should have this testing and when should it be performed?

(04:23)
 What alternative test options are available and how do these compare to our hereditary pancreatitis test?

(08:48)
 How are results used in patient care?